OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
Citation: 2020 BCSECCOM 331
Revocation Order
CVR Medical Corp.
Under the securities legislation of British Columbia (Legislation)
Background
¶ 1 CVR Medical Corp. (the Issuer) is subject to a failure-to-file cease trade order (the FFCTO) issued by the regulator of the British Columbia Securities Commission (the Principal Regulator) on June 19, 2020.
¶ 2 The Issuer has filed the continuous disclosure documents required under the Legislation.
Interpretation
¶ 3 Terms defined in National Instrument 14-101 Definitions and NP 11-207 Failureto-File Cease Trade Orders and Revocations in Multiple Jurisdictions have the same meaning if used in this order, unless otherwise defined.
Order
¶ 4 The Principal Regulator is satisfied that the order to revoke the FFCTO meets the test set out in the Legislation for the Principal Regulator to make this decision.
¶ 5 The decision of the Principal Regulator under the Legislation is that the FFCTO is revoked as it applies to the Issuer.
¶ 6 August 19, 2020
Michael L. Moretto, CPA, CA
Chief of Corporate Disclosure
Corporate Finance